Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sercan Aksoy

Showing results (111-120 of 206) with videos related to

Pageof 21
Sort By:
Expert Review of Molecular Diagnostics|February 26, 2025
The association between blood sodium levels and survival in patients treated with immune checkpoint inhibitorsTaha Koray Sahin, Deniz Can Guven, Mert Durukan, et al.
Journal of Immunotherapy and Precision Oncology|December 25, 2023
Mean Platelet Volume to Lymphocyte Ratio: A New Biomarker Predicting Response in Patients with Solid Tumors Treated with NivolumabHasan Cagri Yildirim, Fatih Kus, Deniz Can Guven, et al.
Expert Review of Anticancer Therapy|February 24, 2025
Modified cachexia index and survival in metastatic breast cancer patients treated with CDK 4-6 inhibitorsOnur Baş, Mert Tokatlı, Mehmet Şavklıyıldız, et al.
European Journal of Breast Health|April 21, 2022
The Comparative Frequency of Breast Cancer-Related Lymphedema Determined by Bioimpedance Spectroscopy and Circumferential MeasurementsPınar Borman, Ayşegül Yaman, Lütfi Doğan, et al.
Expert Review of Anticancer Therapy|January 8, 2025
The association between HALP score and survival in patients treated with immune checkpoint inhibitorsTaha Koray Sahin, Deniz Can Guven, Mert Durukan, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|March 25, 2014
Evaluation of erectile dysfunction risk factors in young male survivors of colorectal cancerMehmet A N Sendur, Sercan Aksoy, Nuriye Y Ozdemir, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|May 18, 2013
Detection of circulating tumor cells in breast cancer patients: prognostic predictive roleIbrahim Turker, Ummugul Uyeturk, Ozlem Uysal Sonmez, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|April 21, 2021
The burden of polypharmacy and drug-drug interactions in older cancer patients treated with immunotherapyDeniz C Guven, Gozde Kavgaci, Oktay H Aktepe, et al.
Current Medical Research and Opinion|January 15, 2015
Comparison of the long term cardiac effects associated with 9 and 52 weeks of trastuzumab in HER2-positive early breast cancerMehmet Ali Nahit Şendur, Sercan Aksoy, Hikmet Yorgun, et al.
International Journal of Clinical Oncology|October 18, 2021
HER2-low breast cancer could be associated with an increased risk of brain metastasisDeniz Can Guven, Mehmet Burak Kaya, Burak Fedai, et al.
Pageof 21

Showing results (111-120 of 206) with videos related to

Sort By:
Pageof 21
Expert Review of Molecular Diagnostics|February 26, 2025
The association between blood sodium levels and survival in patients treated with immune checkpoint inhibitorsTaha Koray Sahin, Deniz Can Guven, Mert Durukan, et al.
Journal of Immunotherapy and Precision Oncology|December 25, 2023
Mean Platelet Volume to Lymphocyte Ratio: A New Biomarker Predicting Response in Patients with Solid Tumors Treated with NivolumabHasan Cagri Yildirim, Fatih Kus, Deniz Can Guven, et al.
Expert Review of Anticancer Therapy|February 24, 2025
Modified cachexia index and survival in metastatic breast cancer patients treated with CDK 4-6 inhibitorsOnur Baş, Mert Tokatlı, Mehmet Şavklıyıldız, et al.
European Journal of Breast Health|April 21, 2022
The Comparative Frequency of Breast Cancer-Related Lymphedema Determined by Bioimpedance Spectroscopy and Circumferential MeasurementsPınar Borman, Ayşegül Yaman, Lütfi Doğan, et al.
Expert Review of Anticancer Therapy|January 8, 2025
The association between HALP score and survival in patients treated with immune checkpoint inhibitorsTaha Koray Sahin, Deniz Can Guven, Mert Durukan, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|March 25, 2014
Evaluation of erectile dysfunction risk factors in young male survivors of colorectal cancerMehmet A N Sendur, Sercan Aksoy, Nuriye Y Ozdemir, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|May 18, 2013
Detection of circulating tumor cells in breast cancer patients: prognostic predictive roleIbrahim Turker, Ummugul Uyeturk, Ozlem Uysal Sonmez, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|April 21, 2021
The burden of polypharmacy and drug-drug interactions in older cancer patients treated with immunotherapyDeniz C Guven, Gozde Kavgaci, Oktay H Aktepe, et al.
Current Medical Research and Opinion|January 15, 2015
Comparison of the long term cardiac effects associated with 9 and 52 weeks of trastuzumab in HER2-positive early breast cancerMehmet Ali Nahit Şendur, Sercan Aksoy, Hikmet Yorgun, et al.
International Journal of Clinical Oncology|October 18, 2021
HER2-low breast cancer could be associated with an increased risk of brain metastasisDeniz Can Guven, Mehmet Burak Kaya, Burak Fedai, et al.
Pageof 21